Nexium Buyers Fight Bid To Nix Experts In Pay-For-Delay Trial
Plaintiffs in an upcoming pay-for-delay trial in multidistrict litigation against AstraZeneca PLC and Teva Pharmaceutical Industries Ltd. over the heartburn drug Nexium on Tuesday shot back at the companies' attempt to...To view the full article, register now.
Already a subscriber? Click here to view full article